NEWS
PolyNovo director pockets near-$2m in share selloff today
MELBOURNE: Mid-cap burn wounds specialist Polynovo’s long-time director Bruce Rathie has pocketed nearly ... read more
Drug developer rattles tin for another cash dollop
MELBOURNE: Neurological diseases drug development company Actinogen Medical, capitalised at $95 million on ... read more